Doug Schenkel, Cowen’s Life Science & Diagnostic Tools analyst speaks with Nathan Ledeboer, Ph.D.Professor, Pathology and Medical Director of Microbiology and Molecular Diagnostics Laboratories, Froedtert & the Medical College of Wisconsin. They discuss how COVID-19 testing has evolved over the past several weeks and some current bottlenecks contributing to the inability to test on a wide scale basis. They also speak about the broader use of molecular diagnostics and how diagnostic tests such as serologic tests can be used to reopen the economy.
Press play below to listen to their conversation.
Doug Schenkel, Managing Director, Health Care – Life Science & Diagnostic Tools
Nathan Ledeboer, Ph.D.
Nathan Ledeboer, Ph.D. is Professor of Pathology and Medical Director of Microbiology and Molecular Diagnostics Laboratories at Froedtert & the Medical College of Wisconsin. Dr. Ledeboer’s primary responsibility is for the medical and technical oversight of the Clinical Microbiology and Molecular Diagnostics Laboratories. In this role he oversees development and implementation of new assays, oversees and sign out all testing performed in these laboratories, and consults with physician colleagues regarding test results and selection. His research interests include the development of rapid molecular techniques for detection of infectious diseases and molecular detection and epidemiology of respiratory viruses.
Get the Full Report
If you’re already a member of our Research portal, log in.Log In
If not, reach out to us directly for more information.